E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma.
D000328:Adult; D000368:Aged; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D006316:Hearing Loss, High-Frequency / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
D003404:Creatinine; D002945:Cisplatin